Pharmaceuticals & Health Care Research

Available Actions

With a Sectors account, you can add Pharmaceuticals & Health Care Research to your watchlist and use our Data Exporter to download the data in CSV or JSON format.

Export Data

Export the data for Pharmaceuticals & Health Care Research as a CSV or a full JSON (standard plan+).

Indonesia Sector Highlight: Pharmaceuticals & Health Care Research

The Pharmaceuticals & Health Care Research subsector on the Indonesia Stock Exchange encompasses companies involved in the pharmaceuticals industry. This subsector plays a major role in Indonesia's market due to several factors. Firstly, the country's growing population and increasing healthcare needs create a significant demand for pharmaceutical products. Additionally, the government's focus on improving healthcare infrastructure and expanding access to healthcare services further drives the growth of this subsector. Moreover, Indonesia's potential as a hub for pharmaceutical research and development attracts both domestic and international companies, leading to increased investments and advancements in the industry. At this moment, this sub-sector appears to be in a bearish market sentiment, with a total market cap depreciation of approximately -20% over the past 365 days. It's possible that around 7 companies within this sub-sector may have encountered a negative market cap change, while it seems that only about 4 companies might have experienced a positive market cap change, indicating a challenging market environment. Notable companies in this subsector, based on market capitalization, include Kalbe Farma Tbk, PT Industri Jamu Dan Farmasi Sido Muncul Tbk, Tempo Scan Pacific Tbk, PT Soho Global Health Tbk, and Kimia Farma Tbk.

P/E Value

The Pharmaceuticals & Health Care Research sub-sector is typically considered defensive due to the consistent demand for healthcare products regardless of economic conditions. Historically, the P/E values for this sub-sector have been moderate. The current lower P/E values compared to last year could be influenced by factors such as increased competition, regulatory ...

11.54

Price to Earnings

Pharmaceuticals & Health Care Research Sector P/E11.54
The Price-to-Earnings (P/E) ratio is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS).
Pharmaceuticals & Health Care Research Weighted Sector P/E21.22
The weighted average P/E ratio is a measure of the average P/E ratio of the companies in the sector, weighted by market capitalization.
Indonesia Stocks Avg. P/E8.44

Resilience & Health Index

In the Pharmaceuticals & Health Care Research sub-sector of the IDX, with 13 companies, the average price changes in the last 30 days placed it at 30th in the sub-sector ranking, performing worse than the overall IDX average. This could be due to factors such as regulatory challenges, high research and development costs, and intense competition within the sector. The lack of ...

7.9

Sector Health Score

Pharmaceuticals & Health Care Research Sector Max Drawdown-0.31
The maximum drawdown is the maximum loss from a peak to a trough of a portfolio, before a new peak is attained. Maximum Drawdown (MDD) is an indicator of downside risk over a specified time period.
Indonesia Stocks Avg. Max Drawdown-0.32
Pharmaceuticals & Health Care Research RSD (Close)0.11
The RSD (Close) is a measure of the volatility of a stock's daily price change. It is calculated as the standard deviation of each day's logarithmic returns summed over the past 90 days.
Indonesia Stocks Avg. RSD (Close)0.17

Sector Growth Index

In the past year, the Pharmaceuticals & Health Care Research sub-sector in Indonesia has seen a significant decline in average Year on Year (YoY) quarter earnings changes at -780.65%, while experiencing a positive average YoY quarter ...

2.5

Sector Growth Score

Trailing 3Y Pharmaceuticals & Health Care Research Sector Growth+1.48%
This uses geometric mean to compute a measure of the sector's revenue growth over the last 3 years.
Pharmaceuticals & Health Care Research Current Revenue Growth8.42%
The change in revenue this quarter compared to the same period a year ago.
Pharmaceuticals & Health Care Research Current Earnings Growth-761.72%
The change in earnings per share (EPS) this quarter compared to the same period a year ago.
Pharmaceuticals & Health Care Research 1Y Market Cap Growth-9.45%
The change in market capitalization relative to the same period a year ago.
Pharmaceuticals & Health Care Research Recent Performance39th
Recent growth beats 39% of all sectors in Indonesia.
Pharmaceuticals & Health Care Research '25 Revenue Growth Forecast+15.33%
The estimated change in revenue for the Pharmaceuticals & Health Care Research sector in 2025.
Pharmaceuticals & Health Care Research '25 Earnings Growth Forecast+16.41%
The estimated change in earnings for the Pharmaceuticals & Health Care Research sector in 2025.

Top Companies

Revenue and Profit are the respective sums of the trailing twelve months (TTM) data, or 4 most recent quarters, while Growth is the year-on-year revenue growth rate.

Most profitable companies in Pharmaceuticals & Health Care Research

Company

Profit (billion)

2868.59

1040.86

1016.10

440.54

236.35

Key Figures

Pharmaceuticals & Health Care Research companies on IDX

13

Total Market Cap. (IDR)

IDR 122.44T

0.99% of total market cap. on IDX
Sector P/E Values

11.5

Companies in this sector have a range of -10x to 25x
Sector CAGR

> 10%

Compound Annual Revenue Growth of 8.42%

Pharmaceuticals & Health Care Research Sector Performance

IDR 122.44T

Sector Market Cap. (IDR, trillion)
  1. Last 4 Quarters

  2. Prev 4 Quarters

Sector Composition

Sector Valuation

Historical valuation of companies in Pharmaceuticals & Health Care Research
More than 5% deviation of median from the last 3 years
Within 5% deviation of median of last 3 years
TTM: Trailing Twelve Months (TTM)
Metric2020202120222023Current (TTM)
Price/Equity25.3820.5811.8311.6211.54Lower than average of last 3 yearsRanked 21 of all sectors
Price/Book2.852.421.891.722.19Lower than average of last 3 yearsRanked 30 of all sectors
Price/Sales1.881.140.940.790.99Lower than average of last 3 years
Price/Cash Flow20.419.8118.668.0412.29Lower than average of last 3 yearsRanked 29 of all sectors

Executive Summary

Sector Performance

1W

+0.1%

1Y

-9.4%

YTD

+1.8%

Trailing 12 Months

Overall -9.4%

−0.4−0.20.20.40.60.8

Positive

Neutral (Within <2.5%)

Negative

Sector Percentile

39%

35
55
75
0
100

This sector has a return that beats 39% of all sectors on the Indonesia Stock Exchange over the past 12 months.

Sector Dividend Yield

2.73%

Dividend-paying companies in this sector pay out a dividend yield of 2.73% on average over the past 12 months. This beats the average dividend yield of all companies on IDX, which is around 3.41%.

Sector Stabillity

92%

35
55
75
0
100

This sector is fairly stable, with a RSD (Relative Standard Deviation) of 11%. Companies on IDX have an average RSD of 14%. This gives the sector a score of 92%.

RSD (Relative Standard Deviation)92%
The relative standard deviation, caluclated from the S.D of the sector's returns.
Max Drawdown-30.63%
The maximum loss from a peak to a trough during a specific period (TTM).

This past month

Over the last month, stocks in the Pharmaceuticals & Health Care Research sector has remained flat, although notably PT Ikapharmindo Putramas Tbk. has gained 22.02% in the last month.

Current quarter

This quarter, the sector has seen an average revenue growth of 8.42% compared to the same quarter last year.
When it comes to earnings, the sector has seen an average decline of -761.72% compared to the same quarter in 2023. Much of this growth is driven by the following companies:
SCPI.JK(+50.7%), SOHO.JK(+18.8%), SIDO.JK(+16.1%), KAEF.JK(+10.1%), TSPC.JK(+6.4%).

Last 12 Months

Companies in the Pharmaceuticals & Health Care Research sector have seen a -9.4% change in market cap over the last 12 months. Investors have become pessimistic on the sector couple with macroeconomic factors that might be strong headwinds for the sector.

Most of the last 12 months in the Pharmaceuticals & Health Care Research sector has been positive with November (+92.7%), June (+3.1%) and May (+3.0%) being the best performing months.

Sector Valuation

Has the Pharmaceuticals & Health Care Research sector valuation in Indonesia changed over the past 12 months?

Price to Earnings Ratio

  • The Pharmaceuticals & Health Care Research sector is trading at a median PE ratio of 11.54x, which is lower than its 3-year historical average PE of 21.22x. This puts the sector in the undervalued category based on its historical valuation.
  • Companies in the Pharmaceuticals & Health Care Research have a considerable large range of PE ratio, going between -10x to 25x.This makes it necessary to consider the outliers in the sector, and adjust for the respective market caps of each company to prevent any skewing of the data.
  • To add some perspective across the value disparity, among the top gainers in the last month, PT Industri Jamu Dan Farmasi Sido Muncul Tbk commands a premium with a PE ratio of 21.47 while PT Phapros Tbk is trading at a PE ratio of only -10.49.
  • When weighted by market cap, the Pharmaceuticals & Health Care Research sector is trading at a PE ratio of 21.22x as compared to the unweighted PE ratio of 11.54x. The unweighted sector median is considered a slight premium (1.4x) to the overall IDX median of 8.44x.
  • The Pharmaceuticals & Health Care Research sector is trading at a PE ratio (11.54) that represents a substantial discount to its historical average (17.36).

Sector Gainers

IKPM Logo
PT Ikapharmindo Putramas Tbk.
IKPM.JK
Last Trading Day

IDR 266.00

1 Month

+22.02%

KAEF Logo
Kimia Farma Tbk.
KAEF.JK
Last Trading Day

IDR 635.00

1 Month

+13.39%

1 Year

-24.85%

P/E Ratio

-2.22

PEHA Logo
PT Phapros Tbk
PEHA.JK
Last Trading Day

IDR 352.00

1 Month

+9.32%

1 Year

-49.71%

P/E Ratio

-10.49

MERK Logo
Merck Tbk
MERK.JK
Last Trading Day

IDR 4,010.00

1 Month

+4.16%

1 Year

-16.11%

P/E Ratio

11.55

SIDO Logo
PT Industri Jamu Dan Farmasi Sido Muncul Tbk
SIDO.JK
Last Trading Day

IDR 745.00

1 Month

+2.76%

1 Year

+7.97%

P/E Ratio

21.47

Filings of Companies in Pharmaceuticals & Health Care Research Sector

No noteworthy filings to report on

    Sectors, Indonesia's Financial Data Layer

    We hate spam as much as you do. We do not resell your data.

    Email us at sectors@supertype.ai for enquiries on using Sectors for your organization.

    © 2024 Supertype Pte. Ltd.
    (and subsidiary PT. Supertype Teknologi Nusantara)